Physician profile
Maybin Simfukwe
NPI 1689635559
$7,539.09
in general payments reported to CMS, 2019-2025
32 companies · $1,532 in 2025
The $1,532 reported for 2025 was more than what 86% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $333 · 2021: $762 · 2022: $1,054 · 2023: $1,220 · 2024: $1,816 · 2025: $1,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,540 · Education: $28.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,539.98 |
| Education | $28.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,414.31 | 2019-2025 | Jynarque, Voyxact |
| Bayer Healthcare Pharmaceuticals INC. | $1,200.38 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $934.00 | 2019-2025 | Farxiga, Lokelma |
| Amgen INC. | $661.50 | 2019-2025 | Tavneos, Krystexxa |
| Horizon Therapeutics Plc | $409.22 | 2019-2023 | Krystexxa |
| Calliditas Therapeutics US INC. | $290.29 | 2022-2025 | Tarpeyo |
| Glaxosmithkline, LLC. | $247.18 | 2021-2023 | Benlysta |
| Akebia Therapeutics INC | $245.53 | 2019-2024 | Vafseo, Auryxia |
| Daiichi Sankyo INC. | $213.11 | 2020-2024 | Injectafer |
| Vifor Pharma, INC. | $206.97 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.66 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $165.09 | 2023-2025 | Ozempic |
| Travere Therapeutics, INC. | $146.18 | 2023-2025 | |
| Ani Pharmaceuticals, INC. | $127.64 | 2023-2025 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $117.97 | 2021-2023 | Ultomiris |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $115.74 | 2024-2025 | Rayaldee |
| Fresenius USA Marketing, INC. | $114.58 | 2019-2025 | Velphoro, Optiflux |
| Medtronic, INC. | $109.93 | 2025 | Symplicity G3 |
| Baxter Healthcare | $105.84 | 2019-2024 | Renal - Pd |
| Takeda Pharmaceuticals U.S.A., INC. | $94.20 | 2022-2025 | Gattex |
| Alnylam Pharmaceuticals INC. | $81.29 | 2021-2024 | Givlaari, Oxlumo |
| Mallinckrodt Hospital Products INC. | $73.25 | 2024-2025 | Terlivaz |
| Scpharmaceuticals INC. | $51.24 | 2025 | |
| Novartis Pharmaceuticals Corporation | $41.89 | 2023-2025 | |
| Nevro Corp. | $28.79 | 2024 | Senza |
| Nuwellis, INC. | $26.12 | 2024 | Aquadex Smartflow Console |
| Lilly USA, LLC | $25.34 | 2024 | Jardiance |
| Ultragenyx Pharmaceutical INC. | $20.40 | 2020 | |
| Allergan, INC. | $19.05 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.43 | 2019 | |
| Outset Medical INC | $9.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maybin Simfukwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.